Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis

doi:10.3748/wjg.v13.i34.4593

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3261)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

387

HTML

2381

Figures (1-4)

312

Tables (1-1)

181

Sum=3261

Sep 14, 2007 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Sep 14, 2007; 13(34): 4593-4597
Published online Sep 14, 2007. doi: 10.3748/wjg.v13.i34.4593

Full Size Figure Download Figure

Figure 4 Kaplan-Meyer analysis of the patients with pancreatic cancer by BNIP3 immunostaining patterns. The mean survival time of patients with punctate perinuclear staining group was 20 mo, diffuse cytoplasmic staining group was 26 mo, and negative/faint-staining group was 95 mo. Each group was comparable in terms of tumor stage and adjuvant therapies.

Citation: Ishida M, Sunamura M, Furukawa T, Akada M, Fujimura H, Shibuya E, Egawa S, Unno M, Horii A. Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis. World J Gastroenterol 2007; 13(34): 4593-4597
URL: https://www.wjgnet.com/1007-9327/full/v13/i34/4593.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i34.4593